Literature DB >> 27408356

Clinical Presentation of Inadvertent Intrathecal Vincristine Masquerading Guillain-Barre Syndrome.

Agni Sekhar Saha1, Md Fekarul Islam2, Sukanta Bhattacharya2, Prabhas Prasun Giri2.   

Abstract

Vincristine, a potent chemotherapeutic agent, is highly neurotoxic. If given intrathecally by accident it is almost always fatal. We are reporting a 6 year old girl with acute lymphoblastic leukaemia in complete remission, who was given inadvertent intrathecal Vincristine instead of Methotrexate. She developed gradually progressive quadriplegia and respiratory paralysis requiring prolonged mechanical ventilation, initially mimicking Guillain-Barre Syndrome, both clinically and electro-physiologically. She also developed progressive encephalopathy. The clinical deterioration subsequently plateaued without any significant improvement and after more than 5 months, she finally expired.

Entities:  

Keywords:  ALL; GB syndrome; Intrathecal vincristine

Year:  2016        PMID: 27408356      PMCID: PMC4925561          DOI: 10.1007/s12288-016-0666-y

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  4 in total

Review 1.  Inadvertent intrathecal vincristine administration: a neurosurgical emergency. Case report.

Authors:  Maher Qweider; Joachim M Gilsbach; Veit Rohde
Journal:  J Neurosurg Spine       Date:  2007-03

2.  Preventing vincristine administration errors: Does evidence support minibag infusions?

Authors:  Lisa Schulmeister
Journal:  Clin J Oncol Nurs       Date:  2006-04       Impact factor: 1.027

3.  Vincristine induced neurotoxicity in cancer patients.

Authors:  Sunil Gomber; Pooja Dewan; Devender Chhonker
Journal:  Indian J Pediatr       Date:  2010-01       Impact factor: 1.967

4.  Intrathecal vincristine: fatal myeloencephalopathy despite cerebrospinal fluid perfusion.

Authors:  Andrés Alcaraz; Corsino Rey; Andrés Concha; Alberto Medina
Journal:  J Toxicol Clin Toxicol       Date:  2002
  4 in total
  2 in total

1.  Inadvertent intrathecal administration of daunomycin resulting in fatality: Case report and therapeutic considerations.

Authors:  Sauson Soldozy; Anant Patel; Kurt Yaeger; Daniel Felbaum; Steven M Spitz; Hasan R Syed; M Nathan Nair
Journal:  eNeurologicalSci       Date:  2020-11-28

Review 2.  Neuraxial and peripheral misconnection events leading to wrong-route medication errors: a comprehensive literature review.

Authors:  Eugene R Viscusi; Vincent Hugo; Klaus Hoerauf; Frederick S Southwick
Journal:  Reg Anesth Pain Med       Date:  2020-11-03       Impact factor: 6.288

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.